Below is a curated list of published studies related to different aspects of Attention Deficit / Hyperactivity Disorder (ADHD) in Saudi Arabia, including prevalence, awareness, diagnosis, language and communication, and review articles.
Additional studies from Saudi Arabia, including topics not featured on this page, are available in the research library. We also maintain a list of ADHD-related theses that have been made available online. If you would like your research featured here, or know of any publications in or about ADHD in KSA that you believe should be included here, please get in touch by email at research @ adhd.org.sa.
Note: Unless specifically stated, these studies were neither conducted by nor supported by the Saudi ADHD Society, and are provided as a resource for researchers only.
Review Articles
Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review
PLoS ONE
10.1371/journal.pone.0219239Abstract
Background and objective: High quality evidence-based clinical practice guidelines (CPGs) have a major impact on the appropriate diagnosis and management and positive outcomes. The evidence-based healthcare for patients with attention deficit hyperactive disorder (ADHD) is challenging. The objective of this study was to appraise the quality of published CPGs for ADHD.
Methods: A systematic review was conducted for ADHD CPGs using CPG databases, DynaMed, PubMed, and Google Scholar. The quality of each included CPG was appraised by three independent appraisers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.
Results: Six CPGs were critically reviewed. The AGREE II standardized domain scores revealed variation between the quality of these CPGs with the National Institute of Health and Care Excellence (NICE), University of Michigan Health System, and American Academy of Pediatrics CPGs as the top three. Overall, the recommendations for management of ADHD were similar in these CPGs.
Conclusions: Reporting of CPG development is often poorly documented. Guideline development groups should aim to follow the AGREE II criteria to improve the standards and quality of CPGs. The NICE CPG showed the best quality. Embedding the AGREE II appraisal of CPGs in the training and education of healthcare providers is recommended.
Note: This study was conducted as part of the Saudi ADHD Society’s unified ADHD Clinical Practice Guidelines Project, strategic project #7.2 for the period 2017-2019. The project received approval from the Ministry of Labor and Social Development (No. 52476) on 5/8/1438. The project is entirely funded by the Saudi ADHD Society. No funding was received from any pharmaceutical or industrial company.
Keywords
Diagnosis, Review, ADHD, AGREE-II, Clinical Practice Guidelines, Systematic Review, CPGCitation
[research_citation style="APA" pubtype="journal" authors="Yasser Sami Amer,Haya Faisal Al-Joudi,Jeremy L Varnham,Fahad A Bashiri,Muddathir Hamad Hamad,Saleh M Al-Salehi,Hadeel Fakhri Daghash,Turki Homod Albatti," year="2019" title="Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review" volume="14" issue="7" journal="PLoS ONE" shortjournal="PLoS ONE" startpage="e0219239" endpage="" articlenum="" doi="10.1371/journal.pone.0219239"]Link to this page: https://res.adhd.org.sa/doi/10.1371/journal.pone.0219239
Prevalence
Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review
PLoS ONE
10.1371/journal.pone.0219239Abstract
Background and objective: High quality evidence-based clinical practice guidelines (CPGs) have a major impact on the appropriate diagnosis and management and positive outcomes. The evidence-based healthcare for patients with attention deficit hyperactive disorder (ADHD) is challenging. The objective of this study was to appraise the quality of published CPGs for ADHD.
Methods: A systematic review was conducted for ADHD CPGs using CPG databases, DynaMed, PubMed, and Google Scholar. The quality of each included CPG was appraised by three independent appraisers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.
Results: Six CPGs were critically reviewed. The AGREE II standardized domain scores revealed variation between the quality of these CPGs with the National Institute of Health and Care Excellence (NICE), University of Michigan Health System, and American Academy of Pediatrics CPGs as the top three. Overall, the recommendations for management of ADHD were similar in these CPGs.
Conclusions: Reporting of CPG development is often poorly documented. Guideline development groups should aim to follow the AGREE II criteria to improve the standards and quality of CPGs. The NICE CPG showed the best quality. Embedding the AGREE II appraisal of CPGs in the training and education of healthcare providers is recommended.
Note: This study was conducted as part of the Saudi ADHD Society’s unified ADHD Clinical Practice Guidelines Project, strategic project #7.2 for the period 2017-2019. The project received approval from the Ministry of Labor and Social Development (No. 52476) on 5/8/1438. The project is entirely funded by the Saudi ADHD Society. No funding was received from any pharmaceutical or industrial company.
Keywords
Diagnosis, Review, ADHD, AGREE-II, Clinical Practice Guidelines, Systematic Review, CPGCitation
[research_citation style="APA" pubtype="journal" authors="Yasser Sami Amer,Haya Faisal Al-Joudi,Jeremy L Varnham,Fahad A Bashiri,Muddathir Hamad Hamad,Saleh M Al-Salehi,Hadeel Fakhri Daghash,Turki Homod Albatti," year="2019" title="Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review" volume="14" issue="7" journal="PLoS ONE" shortjournal="PLoS ONE" startpage="e0219239" endpage="" articlenum="" doi="10.1371/journal.pone.0219239"]Link to this page: https://res.adhd.org.sa/doi/10.1371/journal.pone.0219239
Awareness and Attitudes
Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review
PLoS ONE
10.1371/journal.pone.0219239Abstract
Background and objective: High quality evidence-based clinical practice guidelines (CPGs) have a major impact on the appropriate diagnosis and management and positive outcomes. The evidence-based healthcare for patients with attention deficit hyperactive disorder (ADHD) is challenging. The objective of this study was to appraise the quality of published CPGs for ADHD.
Methods: A systematic review was conducted for ADHD CPGs using CPG databases, DynaMed, PubMed, and Google Scholar. The quality of each included CPG was appraised by three independent appraisers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.
Results: Six CPGs were critically reviewed. The AGREE II standardized domain scores revealed variation between the quality of these CPGs with the National Institute of Health and Care Excellence (NICE), University of Michigan Health System, and American Academy of Pediatrics CPGs as the top three. Overall, the recommendations for management of ADHD were similar in these CPGs.
Conclusions: Reporting of CPG development is often poorly documented. Guideline development groups should aim to follow the AGREE II criteria to improve the standards and quality of CPGs. The NICE CPG showed the best quality. Embedding the AGREE II appraisal of CPGs in the training and education of healthcare providers is recommended.
Note: This study was conducted as part of the Saudi ADHD Society’s unified ADHD Clinical Practice Guidelines Project, strategic project #7.2 for the period 2017-2019. The project received approval from the Ministry of Labor and Social Development (No. 52476) on 5/8/1438. The project is entirely funded by the Saudi ADHD Society. No funding was received from any pharmaceutical or industrial company.
Keywords
Diagnosis, Review, ADHD, AGREE-II, Clinical Practice Guidelines, Systematic Review, CPGCitation
[research_citation style="APA" pubtype="journal" authors="Yasser Sami Amer,Haya Faisal Al-Joudi,Jeremy L Varnham,Fahad A Bashiri,Muddathir Hamad Hamad,Saleh M Al-Salehi,Hadeel Fakhri Daghash,Turki Homod Albatti," year="2019" title="Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review" volume="14" issue="7" journal="PLoS ONE" shortjournal="PLoS ONE" startpage="e0219239" endpage="" articlenum="" doi="10.1371/journal.pone.0219239"]Link to this page: https://res.adhd.org.sa/doi/10.1371/journal.pone.0219239
Diagnosis
Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review
PLoS ONE
10.1371/journal.pone.0219239Abstract
Background and objective: High quality evidence-based clinical practice guidelines (CPGs) have a major impact on the appropriate diagnosis and management and positive outcomes. The evidence-based healthcare for patients with attention deficit hyperactive disorder (ADHD) is challenging. The objective of this study was to appraise the quality of published CPGs for ADHD.
Methods: A systematic review was conducted for ADHD CPGs using CPG databases, DynaMed, PubMed, and Google Scholar. The quality of each included CPG was appraised by three independent appraisers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.
Results: Six CPGs were critically reviewed. The AGREE II standardized domain scores revealed variation between the quality of these CPGs with the National Institute of Health and Care Excellence (NICE), University of Michigan Health System, and American Academy of Pediatrics CPGs as the top three. Overall, the recommendations for management of ADHD were similar in these CPGs.
Conclusions: Reporting of CPG development is often poorly documented. Guideline development groups should aim to follow the AGREE II criteria to improve the standards and quality of CPGs. The NICE CPG showed the best quality. Embedding the AGREE II appraisal of CPGs in the training and education of healthcare providers is recommended.
Note: This study was conducted as part of the Saudi ADHD Society’s unified ADHD Clinical Practice Guidelines Project, strategic project #7.2 for the period 2017-2019. The project received approval from the Ministry of Labor and Social Development (No. 52476) on 5/8/1438. The project is entirely funded by the Saudi ADHD Society. No funding was received from any pharmaceutical or industrial company.
Keywords
Diagnosis, Review, ADHD, AGREE-II, Clinical Practice Guidelines, Systematic Review, CPGCitation
[research_citation style="APA" pubtype="journal" authors="Yasser Sami Amer,Haya Faisal Al-Joudi,Jeremy L Varnham,Fahad A Bashiri,Muddathir Hamad Hamad,Saleh M Al-Salehi,Hadeel Fakhri Daghash,Turki Homod Albatti," year="2019" title="Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review" volume="14" issue="7" journal="PLoS ONE" shortjournal="PLoS ONE" startpage="e0219239" endpage="" articlenum="" doi="10.1371/journal.pone.0219239"]Link to this page: https://res.adhd.org.sa/doi/10.1371/journal.pone.0219239
Language & Communication
Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review
PLoS ONE
10.1371/journal.pone.0219239Abstract
Background and objective: High quality evidence-based clinical practice guidelines (CPGs) have a major impact on the appropriate diagnosis and management and positive outcomes. The evidence-based healthcare for patients with attention deficit hyperactive disorder (ADHD) is challenging. The objective of this study was to appraise the quality of published CPGs for ADHD.
Methods: A systematic review was conducted for ADHD CPGs using CPG databases, DynaMed, PubMed, and Google Scholar. The quality of each included CPG was appraised by three independent appraisers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.
Results: Six CPGs were critically reviewed. The AGREE II standardized domain scores revealed variation between the quality of these CPGs with the National Institute of Health and Care Excellence (NICE), University of Michigan Health System, and American Academy of Pediatrics CPGs as the top three. Overall, the recommendations for management of ADHD were similar in these CPGs.
Conclusions: Reporting of CPG development is often poorly documented. Guideline development groups should aim to follow the AGREE II criteria to improve the standards and quality of CPGs. The NICE CPG showed the best quality. Embedding the AGREE II appraisal of CPGs in the training and education of healthcare providers is recommended.
Note: This study was conducted as part of the Saudi ADHD Society’s unified ADHD Clinical Practice Guidelines Project, strategic project #7.2 for the period 2017-2019. The project received approval from the Ministry of Labor and Social Development (No. 52476) on 5/8/1438. The project is entirely funded by the Saudi ADHD Society. No funding was received from any pharmaceutical or industrial company.
Keywords
Diagnosis, Review, ADHD, AGREE-II, Clinical Practice Guidelines, Systematic Review, CPGCitation
[research_citation style="APA" pubtype="journal" authors="Yasser Sami Amer,Haya Faisal Al-Joudi,Jeremy L Varnham,Fahad A Bashiri,Muddathir Hamad Hamad,Saleh M Al-Salehi,Hadeel Fakhri Daghash,Turki Homod Albatti," year="2019" title="Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review" volume="14" issue="7" journal="PLoS ONE" shortjournal="PLoS ONE" startpage="e0219239" endpage="" articlenum="" doi="10.1371/journal.pone.0219239"]Link to this page: https://res.adhd.org.sa/doi/10.1371/journal.pone.0219239